Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2026-02-04 @ 5:18 AM
Study NCT ID:
NCT04777994
Status:
RECRUITING
Last Update Posted:
2025-12-23
First Post:
2021-02-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Sponsor:
Calico Life Sciences LLC
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced Solid Tumor Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Cancer | View |
| None | Tumor | View |
| None | anti-PD-1 | View |
| None | ABBV-CLS-484 | View |
| None | clear cell renal cell carcinoma (ccRCC) | View |
| None | head and neck squamous cell carcinoma (HNSCC) | View |
| None | non-small cell lung cancer (NSCLC) | View |
| None | relapsed or refractory (R/R) | View |
| None | Microsatellite instability - high tumors (MSI-H) | View |
| None | Vascular Endothelial Growth Factor Receptor (VEGFR) Tyrosine Kinase Inhibitor (TKI) | View |